Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
University of Toronto
$105,000.00
Antenatal glucocorticoid treatment modifies placental system A transport: Mechanisms behind aberrant nutrient transport
EF 2009-10
Résumé
Synthetic glucocorticoids (sGCs) are administered to pregnant women at risk of preterm labour (PTL) to enhance fetal lung maturation and prevent respiratory distress syndrome. Although sGCs are necessary for fetal survival, their administration has been linked with adverse effects such as reductions in infant birthweight. The risk of delivering a growth restricted fetus is especially common to women who receive sGCs for threatened PTL but end up carrying their pregnancies to term. Since placental nutrient transport is tightly linked to fetal growth, it is of critical importance to understand changes in nutrient delivery throughout pregnancy due to sGC treatment. While the underlying mechanism of sGC-induced reductions in infant birthweight is unknown, impaired placental development and/or function have been implicated. This has been demonstrated as reductions in birthweight occurred from maternal but not fetal administration of sGCs in sheep. Using a mouse model we will determine the effects of maternal GC treatment on placental nutrient transport by administering sGC at mid-gestation and observing the effects both immediately after treatment and at term. We will examine the placental system A transporter as its activity has shown to be critical for normal fetal growth and lowered in placentas from growth restricted fetuses. To test placental transport, we maternally administer a tracer specific for placental system A and measure how much accumulates in the fetus. By comparing the rates of fetal accumulation with sGC treatment against a placebo, we will be able to determine any changes in placental system A activity caused by sGC treatment. We predict that regulation of the system A transporter is dependent on the timing of sGC exposure and that treatment will cause reductions in system A transport at term. This study will be the first to investigate the short and long term changes in placental system A transport across pregnancy due to maternal sGC administration.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
206073
Name
Audette Melanie C
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Antenatal glucocorticoid treatment modifies placental system A transport: Mechanisms behind aberrant nutrient transport
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Amino Acid Transport; Endocrine Regulation; Glucocorticoids; Growth Restriction; Mouse; Placenta; System A
Abstract
Synthetic glucocorticoids (sGCs) are administered to pregnant women at risk of preterm labour (PTL) to enhance fetal lung maturation and prevent respiratory distress syndrome. Although sGCs are necessary for fetal survival, their administration has been linked with adverse effects such as reductions in infant birthweight. The risk of delivering a growth restricted fetus is especially common to women who receive sGCs for threatened PTL but end up carrying their pregnancies to term. Since placental nutrient transport is tightly linked to fetal growth, it is of critical importance to understand changes in nutrient delivery throughout pregnancy due to sGC treatment. While the underlying mechanism of sGC-induced reductions in infant birthweight is unknown, impaired placental development and/or function have been implicated. This has been demonstrated as reductions in birthweight occurred from maternal but not fetal administration of sGCs in sheep. Using a mouse model we will determine the effects of maternal GC treatment on placental nutrient transport by administering sGC at mid-gestation and observing the effects both immediately after treatment and at term. We will examine the placental system A transporter as its activity has shown to be critical for normal fetal growth and lowered in placentas from growth restricted fetuses. To test placental transport, we maternally administer a tracer specific for placental system A and measure how much accumulates in the fetus. By comparing the rates of fetal accumulation with sGC treatment against a placebo, we will be able to determine any changes in placental system A activity caused by sGC treatment. We predict that regulation of the system A transporter is dependent on the timing of sGC exposure and that treatment will cause reductions in system A transport at term. This study will be the first to investigate the short and long term changes in placental system A transport across pregnancy due to maternal sGC administration.
Competitiondate
200910
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Audette, Melanie C
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~